BioCentury
ARTICLE | Company News

Genzyme, Imperial Cancer Research Fund deal

January 29, 1996 8:00 AM UTC

GENZ will work with ICRF's Imperial Cancer Research Technology Ltd. company to identify gene therapy projects targeted at cancer. GENZ will fund any selected projects in exchange for commercial rights...